[{"NetIncomeLoss_1_Q1_USD":2396000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-8000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":45792000.0,"InterestPaidNet_1_Q1_USD":513000.0,"InventoryFinishedGoods_0_Q1_USD":61977000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-9469000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":20200000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-731000.0,"Depreciation_1_Q1_USD":1600000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q1_USD":1751000.0,"InventoryRawMaterialsAndSupplies_0_Q1_USD":18874000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1150000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-1538000.0,"AssetsCurrent_0_Q1_USD":265819000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":171000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":15169000.0,"LongTermDebt_0_Q1_USD":37000000.0,"RestructuringCharges_1_Q1_USD":205000.0,"ContractWithCustomerLiability_0_Q1_USD":28423000.0,"SellingAndMarketingExpense_1_Q1_USD":28971000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":3018000.0,"IncomeTaxesPaidNet_1_Q1_USD":-320000.0,"CommonStockSharesIssued_0_Q1_shares":34096895.0,"ProceedsFromOtherDebt_1_Q1_USD":0.0,"Assets_0_Q1_USD":581368000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-6426000.0,"ShareBasedCompensation_1_Q1_USD":3114000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":10776000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q1_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LongTermDebtCurrent_0_Q1_USD":36523000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":33611000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":14855000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":101000.0,"EarningsPerShareBasic_1_Q1_USD":0.07,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":17940000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":125000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":33782000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":1172000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-162000.0,"AccountsReceivableNetCurrent_0_Q1_USD":91326000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":468000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":2732000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"CommonStockValue_0_Q1_USD":344696000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-4230000.0,"Revenues_1_Q1_USD":114927000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":7257000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":268498000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-731000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.164,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProductWarrantyAccrual_0_Q1_USD":4796000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q1_USD":-142000.0,"Liabilities_0_Q1_USD":172436000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":8181000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":80549000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":26321000.0,"OtherAssetsNoncurrent_0_Q1_USD":20408000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1303000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-4030000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-4139000.0,"ProductWarrantyAccrualPayments_1_Q1_USD":740000.0,"CostsAndExpenses_1_Q1_USD":46688000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-21275000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":3897000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":167264000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1_Q1_USD":-68000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q1_USD":0.0,"Goodwill_0_Q1_USD":149761000.0,"MarketDataRevenue_1_Q1_USD":114927000.0,"ProductWarrantyExpense_1_Q1_USD":341000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":24703000.0,"RepaymentsOfDebt_1_Q1_USD":20000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":33611000.0,"InventoryWorkInProcess_0_Q1_USD":3327000.0,"LiabilitiesCurrent_0_Q1_USD":136476000.0,"DeferredRevenueCurrent_0_Q1_USD":23669000.0,"AccountsPayableCurrent_0_Q1_USD":24486000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1656000.0,"InterestExpense_1_Q1_USD":766000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":24477000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":29551000.0,"LongTermDebtNoncurrent_0_Q1_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":-6494000.0,"GrossProfit_1_Q1_USD":66488000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-1064000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":82970000.0,"ImpairmentChargeOnReclassifiedAssets_1_Q1_USD":136000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":37000000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":9915000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":5311000.0,"InventoryNoncurrent_0_Q1_USD":14711000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-1150000.0,"ShortTermBorrowings_0_Q1_USD":36523000.0,"PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease_1_Q1_USD":94000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":23282000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":85001000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":13233000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":8332000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":12619000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":4028000.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"OperatingIncomeLoss_1_Q1_USD":4520000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":2864000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":6085000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":0.0,"InventoryNet_0_Q1_USD":69467000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":23700000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":266467000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":581368000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3018000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":2512000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":52833000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":6006000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":16276000.0,"EarningsPerShareDiluted_1_Q1_USD":0.07,"CommonStockSharesOutstanding_0_Q1_shares":34096895.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-4962000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-1533000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":73705000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":2422000.0,"DeferredFinanceCostsNet_0_Q1_USD":477000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":6085000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":4700000.0,"StockholdersEquity_0_Q1_USD":408932000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q1_USD":229000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":17864000.0,"SalesTypeAndDirectFinancingLeasesProfitLoss_1_Q1_USD":-6000.0,"OperatingExpenses_1_Q1_USD":61968000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":731000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":14040000.0,"Ticker":"NTUS","CIK":"878526","name":"NATUS MEDICAL INC","OfficialName":"Natus Medical Incorporated Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1152673159.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]